These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 12004135)

  • 1. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.
    Ogawa H; Ishiguro K; Gaubatz S; Livingston DM; Nakatani Y
    Science; 2002 May; 296(5570):1132-6. PubMed ID: 12004135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription. Chromatin control--a place for E2F and Myc to meet.
    La Thangue NB
    Science; 2002 May; 296(5570):1034-5. PubMed ID: 12004105
    [No Abstract]   [Full Text] [Related]  

  • 3. Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter.
    Nicolas E; Roumillac C; Trouche D
    Mol Cell Biol; 2003 Mar; 23(5):1614-22. PubMed ID: 12588981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
    Tyagi S; Chabes AL; Wysocka J; Herr W
    Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression.
    Tommasi S; Pfeifer GP
    Mol Cell Biol; 1995 Dec; 15(12):6901-13. PubMed ID: 8524257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic site-specific recruitment of RBP2 by pocket protein p130 modulates H3K4 methylation on E2F-responsive promoters.
    Zargar ZU; Kimidi MR; Tyagi S
    Nucleic Acids Res; 2018 Jan; 46(1):174-188. PubMed ID: 29059406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.
    Ait-Si-Ali S; Guasconi V; Fritsch L; Yahi H; Sekhri R; Naguibneva I; Robin P; Cabon F; Polesskaya A; Harel-Bellan A
    EMBO J; 2004 Feb; 23(3):605-15. PubMed ID: 14765126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9.
    Oberley MJ; Inman DR; Farnham PJ
    J Biol Chem; 2003 Oct; 278(43):42466-76. PubMed ID: 12909625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
    Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
    Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin.
    Vakoc CR; Mandat SA; Olenchock BA; Blobel GA
    Mol Cell; 2005 Aug; 19(3):381-91. PubMed ID: 16061184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A viral mechanism for remodeling chromatin structure in G0 cells.
    Ghosh MK; Harter ML
    Mol Cell; 2003 Jul; 12(1):255-60. PubMed ID: 12887910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the meiotic genes SMC1beta and STAG3 in somatic cells by E2F6.
    Storre J; Schäfer A; Reichert N; Barbero JL; Hauser S; Eilers M; Gaubatz S
    J Biol Chem; 2005 Dec; 280(50):41380-6. PubMed ID: 16236716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.